Showing results (21-30 of 1,057) with videos related to

Sort By:
Pageof 106
Cardiorenal Medicine|June 7, 2022
Atrial Fibrillation and Anticoagulant Treatment in End-Stage Renal Disease Patients: Where Do We Stand?Luca Di Lullo, Marco Valerio Mariani, Claudio Ronco, et al.
Cardiorenal Medicine|February 4, 2026
Inclisiran in Chronic Kidney Disease patients: a real world experienceAndrea Dello Strologo, Aldo Franculli, Pasquale Saporito, et al.
Diabetes & Metabolic Syndrome|March 16, 2017
The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agentsLuca Di Lullo, Michela Mangano, Claudio Ronco, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 8, 2015
[Troponins and chronic kidney disease]Luca Di Lullo, Vincenzo Barbera, Alberto Santoboni, et al.
Cardiorenal Medicine|March 28, 2023
Artificial Diuresis: Animal Studies on Efficacy and Safety of a New Miniaturized Device for Extracorporeal UltrafiltrationAnna Lorenzin, Luca Sgarabotto, Maria Laura Bacci, et al.
Heart Failure Reviews|August 2, 2015
Fabry's disease: an example of cardiorenal syndrome type 5Aashish Sharma, Marco Sartori, Jose J Zaragoza, et al.
Cardiorenal Medicine|May 1, 2020
Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance NetworkCarlo Lavalle, Luca Di Lullo, Antonio Bellasi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 1, 2017
[Neprilysin inhibition and chronic kidney disease]Luca Di Lullo, Claudio Ronco, Antonio Bellasi, et al.
Nephron. Clinical Practice|January 4, 2011
Right ventricular diastolic function in dialysis patients could be affected by vascular accessLuca Di Lullo, Fulvio Floccari, Pasquale Polito
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Evaluation of adverse drug reactions associated with direct oral anticoagulants recorded in the Italian Pharmacovigilance Network database using a specifically developed risk index]Massimo Uguccioni, Antonio Terranova, Luca Di Lullo
Pageof 106